Medication info
CantaBel A Tablets 16/5/10 mg

CantaBel A Tablets 16/5/10 mg

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›16mg / 1 tabletAmlodipine Besylate›6.94mg / 1 tabletAtorvastatin Calcium›10.85mg / 1 tablet
Manufacturer / importer
Jongkundang Co., Ltd.
Appearance
Bright orange oval film-coated tablet
Packaging
30 tablets/PTP
Approval status
Active

MFDS item code 202200403 · Approved 2022.01.24 · Insurance code 643308930

Summary

Main use
Treatment of essential hypertension, improvement of hyperlipidemia, and prevention of cardiovascular disease
Who takes it
Adults
Adult dose
This medicine should be taken as 1 tablet once daily with water, with or without food. It is recommended to take it at the same time each day (e.g., in the morning), if possible. This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the candesartan cilexetil/amlodipine combination and atorvastatin. For patients taking candesartan cilexetil/amlodipine combination therapy and atorvastatin concomitantly, switching to this medicine (a combination product containing the same amounts of each active ingredient) may be considered for convenience. ○ Candesartan cilexetil/amlodipine combination Before administering the candesartan cilexetil/amlodipine combination, it is recommended that the dose be adjusted using the individual components (candesartan cilexetil or amlodipine). However, if blood pressure is not controlled as described below, switching directly to the candesartan cilexetil/amlodipine combination may be considered. - 8/5 mg: For patients whose blood pressure is not adequately controlled with candesartan cilexetil 8 mg or amlodipine 5 mg. - 16/5 mg: For patients whose blood pressure is not adequately controlled with candesartan cilexetil 16 mg or amlodipine 5 mg. - 16/10 mg: For patients whose blood pressure is not adequately controlled with candesartan cilexetil 16 mg, amlodipine 10 mg, or candesartan cilexetil/amlodipine 16/5 mg. ○ Atorvastatin Patients before and during treatment with atorvastatin should follow a standard cholesterol-lowering diet. Atorvastatin may be taken at any time of day, with or without food. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients who require a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only for patients requiring a reduction in LDL cholesterol of 45 % or more). Atorvastatin is administered once daily at doses ranging from 10 ~ 80 mg. The initial and maintenance doses of atorvastatin should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or titrating the dose, and the dose adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the response to treatment. Patients with homozygous familial hypercholesterolemia Atorvastatin is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not available. ○ Patients with renal impairment: For patients with renal impairment, an initial dose of candesartan cilexetil of 4 mg once daily is recommended; therefore, it is not advisable to use this medicine for initial treatment. ○ Patients with hepatic impairment: For patients with mild to moderate hepatic impairment, an initial dose of candesartan cilexetil of 2 mg once daily is recommended; therefore, it is not advisable to use this medicine for initial treatment.

Ingredients

Manufacturer
Jongkundang Co., Ltd.

Efficacy & effects

Treatment of essential hypertension, improvement of hyperlipidemia, and prevention of cardiovascular disease

  • Primary hypertension
  • myocardial infarction
  • stroke
  • chronic stable angina
  • retinopathy
  • albuminuria
  • hypertension
  • congestive heart failure
  • angina
  • hypercholesterolemia
  • dyslipidemia
  • abnormal beta-lipoproteinemia
View approved original text

This medication is used for patients with primary hypertension whose blood pressure is not adequately controlled with Candesartan Cilexetil and Amlodipine in combination, and only if Atorvastatin needs to be administered simultaneously. Atorvastatin reduces the risk of myocardial infarction, stroke, revascularization procedures, and angina in patients at high risk of coronary heart disease or those with type 2 diabetes. It is also effective in treating hyperlipidemia, helping to lower cholesterol and bad LDL levels while increasing good HDL levels in various types of dyslipidemia patients. This medication is used for the reduction of hypertension and cardiovascular disease risk and for improvement of dyslipidemia.

How to take

Adult dose

This medicine should be taken as 1 tablet once daily with water, with or without food. It is recommended to take it at the same time each day (e.g., in the morning), if possible. This medicine is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the candesartan cilexetil/amlodipine combination and atorvastatin. For patients taking candesartan cilexetil/amlodipine combination therapy and atorvastatin concomitantly, switching to this medicine (a combination product containing the same amounts of each active ingredient) may be considered for convenience. ○ Candesartan cilexetil/amlodipine combination Before administering the candesartan cilexetil/amlodipine combination, it is recommended that the dose be adjusted using the individual components (candesartan cilexetil or amlodipine). However, if blood pressure is not controlled as described below, switching directly to the candesartan cilexetil/amlodipine combination may be considered. - 8/5 mg: For patients whose blood pressure is not adequately controlled with candesartan cilexetil 8 mg or amlodipine 5 mg. - 16/5 mg: For patients whose blood pressure is not adequately controlled with candesartan cilexetil 16 mg or amlodipine 5 mg. - 16/10 mg: For patients whose blood pressure is not adequately controlled with candesartan cilexetil 16 mg, amlodipine 10 mg, or candesartan cilexetil/amlodipine 16/5 mg. ○ Atorvastatin Patients before and during treatment with atorvastatin should follow a standard cholesterol-lowering diet. Atorvastatin may be taken at any time of day, with or without food. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients who require a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only for patients requiring a reduction in LDL cholesterol of 45 % or more). Atorvastatin is administered once daily at doses ranging from 10 ~ 80 mg. The initial and maintenance doses of atorvastatin should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or titrating the dose, and the dose adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the response to treatment. Patients with homozygous familial hypercholesterolemia Atorvastatin is administered at a dose of 10 ~ 80 mg once daily, in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such lipid-lowering treatments are not available. ○ Patients with renal impairment: For patients with renal impairment, an initial dose of candesartan cilexetil of 4 mg once daily is recommended; therefore, it is not advisable to use this medicine for initial treatment. ○ Patients with hepatic impairment: For patients with mild to moderate hepatic impairment, an initial dose of candesartan cilexetil of 2 mg once daily is recommended; therefore, it is not advisable to use this medicine for initial treatment.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during pregnancy; therefore, it should be discontinued immediately if pregnancy is confirmed. If there are muscle-related adverse symptoms or significantly elevated creatine kinase levels in blood tests, the use of this medication should be stopped, and special caution is required for patients at risk of myopathy. Patients allergic to any ingredients in this medication, pregnant or potentially pregnant women, nursing mothers, patients with severe liver disease or cholestasis, and patients with severe renal impairment should not take this medication. Elderly patients, patients with hyperkalemia, those with impaired liver or kidney function, hypotensive patients, and patients with heart valve disease require more careful monitoring when taking this medication. Side effects such as myalgia, headache, dizziness, edema, dyspepsia, and liver function abnormalities may occur; therefore, if symptoms are severe or persistent, consultation with healthcare professionals is necessary. It is particularly important to regularly monitor blood pressure, kidney function, and potassium levels during the use of this medication to detect any abnormal signs early and manage them appropriately. In addition, this medication may interact with various other drugs; thus, patients taking other medications must inform their doctor or pharmacist. During the use of this medication, if sudden muscle pain, muscle weakness, severe fatigue, or fever occur, it is important to immediately inform healthcare professionals and undergo testing. Caution is advised when driving or operating machinery, as dizziness or drowsiness may occur. This medication may increase blood concentration when taken with grapefruit juice; therefore, it is advisable to avoid consuming grapefruit juice. Long-term use of this medication may increase the risk of liver function abnormalities or diabetes, so regular health check-ups are necessary.

Side effects

  • Dizziness
  • headache
  • fainting
  • chest pain
  • swelling
  • palpitations
  • urinary tract infection
  • colon polypectomy
  • low back pain
  • respiratory infection
Show 236 more
  • upper respiratory infection
  • pharyngitis
  • rhinitis
  • weakness
  • fever
  • sensory disturbances
  • dyspepsia
  • gastroenteritis
  • tachycardia
  • heart palpitations
  • increased creatine kinase
  • hyperglycemia
  • hypertriglyceridemia
  • hyperuricemia
  • myalgia
  • epistaxis
  • anxiety
  • depression
  • drowsiness
  • dyspnea
  • rash
  • increased sweating
  • hematuria
  • increased liver enzyme levels
  • hepatitis
  • elevated AST
  • jaundice
  • urticaria
  • pruritus
  • angioedema
  • myalgia
  • weakness
  • elevated creatine kinase
  • increased serum myoglobin
  • rhabdomyolysis
  • arthralgia
  • musculoskeletal pain
  • renal impairment
  • acute kidney failure
  • interstitial pneumonia
  • shock
  • loss of consciousness
  • facial flushing
  • weight gain
  • thirst
  • sleep disturbances
  • decreased libido
  • forgetfulness
  • loss of appetite
  • increased appetite
  • tinnitus
  • gustatory disturbances
  • erectile dysfunction
  • flushing
  • fatigue
  • heart palpitations
  • vertigo
  • drowsiness
  • abdominal pain
  • nausea
  • weakness
  • lethargy
  • pain
  • hypotension
  • vasculitis
  • hypertonia
  • sensory loss
  • sensory disturbances
  • peripheral neuropathy
  • taste abnormalities
  • tremor
  • extrapyramidal disorder
  • erectile dysfunction
  • gynecomastia
  • changes in bowel habits
  • dry mouth
  • dyspepsia
  • gingival hyperplasia
  • pancreatitis
  • vomiting
  • hyperglycemia
  • nasopharyngitis
  • hypoglycemia
  • weight gain
  • loss of appetite
  • constipation
  • abdominal distention
  • diarrhea
  • belching
  • pain in the throat and larynx
  • nosebleed
  • insomnia
  • nightmares
  • sensory disturbances
  • amnesia
  • peripheral neuropathy
  • muscle cramps
  • pain in limbs
  • muscle fatigue
  • rupture complications
  • myopathy
  • myositis
  • tendon disorders
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • thrombocytopenia
  • allergic reactions
  • anaphylaxis
  • cholestasis
  • liver failure
  • blurred vision
  • visual impairment
  • hearing loss
  • angioneurotic edema
  • erythema multiforme
  • mucous membrane syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • hepatitis
  • cholestasis
  • cholestatic jaundice
  • abnormal liver function tests
  • vomiting
  • abdominal abnormalities
  • hepatitis
  • pancreatitis
  • cholestasis
  • cholestatic jaundice
  • abnormal liver function tests
  • gastroenteritis
  • enteritis
  • dry mouth
  • rectal bleeding
  • esophagitis
  • belching
  • glossitis
  • oral ulcer
  • stomatitis
  • gallbladder pain
  • cheilitis
  • gastric and duodenal ulcer
  • dysphagia
  • melena
  • gingival bleeding
  • gastroesophageal reflux
  • bronchitis
  • rhinitis
  • pneumonia
  • dyspnea
  • asthma
  • nosebleed
  • sensory disturbances
  • photosensitivity reactions
  • drowsiness
  • abnormal dreams
  • emotional instability
  • ataxia
  • torticollis
  • facial paralysis
  • hyperactivity
  • depression
  • hypertonia
  • muscle cramps
  • myopathy
  • muscle diseases
  • arthritis
  • bursitis
  • tenosynovitis
  • myasthenia gravis
  • neck pain
  • contracture
  • elevated CK
  • increased serum myoglobin
  • itching
  • skin rash
  • alopecia
  • contact dermatitis
  • dry skin
  • sweating
  • acne
  • urticaria
  • eczema
  • seborrhea
  • skin ulcers
  • erectile dysfunction
  • urinary tract infection
  • frequency of urination
  • cystitis
  • hematuria
  • dysuria
  • kidney stones
  • nocturia
  • epididymitis
  • fibrocystic breast disease
  • vaginal bleeding
  • albuminuria
  • breast enlargement
  • cervical discharge
  • nephritis
  • urinary incontinence
  • urinary retention
  • urgency
  • abnormal ejaculation
  • uterine bleeding
  • discolored urine
  • hypoglycemia
  • hyperglycemia
  • loss of appetite
  • increased appetite
  • lethargy
  • vasomotor edema
  • chest pain
  • angina
  • facial swelling
  • fever
  • neck stiffness
  • generalized edema
  • amblyopia
  • dry eyes
  • refractive errors
  • subconjunctival hemorrhage
  • hearing loss
  • glaucoma
  • palliative care
  • taste loss
  • gustatory disturbances
  • thrombocytopenia
  • leukopenia
  • anemia
  • decreased testosterone
  • increased cholinesterase
  • elevated TSH
  • increased ACTH
  • decreased aldosterone
  • cerebral infarction
  • tachycardia

Not everyone experiences these, and they can vary from person to person.

Storage

Store the medication in a tightly closed container to prevent air or moisture infiltration, and the optimal storage temperature is between 1 to 30 degrees Celsius. Proper storage helps maintain the efficacy of the medication for a longer period.

Appearance and packaging

Appearance

Bright orange oval film-coated tablet

Package unit

30 tablets/PTP

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.